These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17198446)

  • 1. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.
    Ansarin H; Aziz-Jalali MH; Rasi A; Soltani-Arabshahi R
    Arch Iran Med; 2007 Jan; 10(1):7-13. PubMed ID: 17198446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What every physician should know about polycystic ovary syndrome.
    Rosenfield RL
    Dermatol Ther; 2008; 21(5):354-61. PubMed ID: 18844713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.
    Unluhizarci K; Kaltsas G; Kelestimur F
    Eur J Clin Invest; 2012 Jan; 42(1):86-94. PubMed ID: 21623779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.
    Sanchón R; Gambineri A; Alpañés M; Martínez-García MÁ; Pasquali R; Escobar-Morreale HF
    Hum Reprod; 2012 Apr; 27(4):1209-16. PubMed ID: 22343706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical evaluation of hirsutism.
    Somani N; Harrison S; Bergfeld WF
    Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran.
    Hashemipour M; Faghihimani S; Zolfaghary B; Hovsepian S; Ahmadi F; Haghighi S
    Horm Res; 2004; 62(6):278-82. PubMed ID: 15523185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms.
    Di Fede G; Mansueto P; Pepe I; Rini GB; Carmina E
    Fertil Steril; 2010 Jun; 94(1):194-7. PubMed ID: 19338993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
    Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
    Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue.
    Unluhizarci K; Gokce C; Atmaca H; Bayram F; Kelestimur F
    Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):504-9. PubMed ID: 15505757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated prevalence of undiagnosed glucose intolerance from hyperandrogenic anovulation among women requesting electrolysis.
    Dumesic DA; Herrmann RR; O'Brien AM
    Int J Fertil Womens Med; 1997; 42(4):255-60. PubMed ID: 9309459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating androgens in hirsutism.
    Khandekar S; Lata V; Dash RJ
    J Assoc Physicians India; 1989 Oct; 37(10):632-5. PubMed ID: 2632509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of androgen excess among patients with minimal unwanted hair growth.
    Souter I; Sanchez LA; Perez M; Bartolucci AA; Azziz R
    Am J Obstet Gynecol; 2004 Dec; 191(6):1914-20. PubMed ID: 15592272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis.
    Glintborg D; Henriksen JE; Andersen M; Hagen C; Hangaard J; Rasmussen PE; Schousboe K; Hermann AP
    Fertil Steril; 2004 Dec; 82(6):1570-9. PubMed ID: 15589862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group.
    Farah L; Lazenby AJ; Boots LR; Azziz R
    J Reprod Med; 1999 Oct; 44(10):870-4. PubMed ID: 10554748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatology of androgen-related disorders.
    Essah PA; Wickham EP; Nunley JR; Nestler JE
    Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
    Carmina E; Rosato F; Jannì A; Rizzo M; Longo RA
    J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women.
    Davis SR; Knight S; White V; Claridge C; Davis BJ; Bell R
    Gynecol Endocrinol; 2002 Dec; 16(6):443-6. PubMed ID: 12626030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.